🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lei Ye

Nanjing Brain Hospital

ORCID: 0000-0003-0140-8385

Also affiliated with Nanjing Drum Tower Hospital, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Shaanxi University of Chinese Medicine, Nanjing University

NeurosciencePharmacology, Toxicology and PharmaceuticsMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment.

16 citations

Yu Xu, Ruizhi Zheng, Lei Ye, Gang Lv, Zhujun Cao +26 more

15 citations

Zhiwei Xue, Shu Shu, Linjie Yu, Ruomeng Qin, Wenyuan Tao +8 more